RESPONSE TO THALIDOMIDE AND CYCLOSPORINE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME WITHOUT ISOLATED DEL(5Q)

被引：1
|
作者：
Wang, J. [1 ]
Qin, T. [1 ]
Xu, Z. [1 ]
Zhang, Y. [1 ]
Gale, R. [2 ]
Fang, L. [1 ]
Zhang, H. [1 ]
Pan, L. [1 ]
Hu, N. [1 ]
Qu, S. [1 ]
Li, B. [1 ]
Xiao, Z. [1 ]
机构：
[1] Inst Hematol & Blood Dis Hosp, MDS & MPN Ctr, Tianjin, Peoples R China
[2] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30256-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
255
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [41] Analysis of clinical characteristics,treatment response rate and survival of 77 myelodysplastic syndrome patients with del (5q) syndrome
    刘丹
    China Medical Abstracts(Internal Medicine), 2020, 37 (01) : 61 - 61
  • [42] Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)
    Pardanani, A.
    Patnaik, M. M.
    Lasho, T. L.
    Mai, M.
    Knudson, R. A.
    Finke, C.
    Ketterling, R. P.
    McClure, R. F.
    Tefferi, A.
    LEUKEMIA, 2010, 24 (07) : 1370 - 1372
  • [43] Routes of clonal evolution into complex karyotypes in myelodysplastic syndrome patients with del(5q)
    Goehring, G.
    Feurstein, S.
    Thomay, K.
    Hofmann, W.
    Ganser, A.
    Kreipe, H.
    Schlegelberger, B.
    LEUKEMIA RESEARCH, 2013, 37 : S136 - S136
  • [44] Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)
    A Pardanani
    M M Patnaik
    T L Lasho
    M Mai
    R A Knudson
    C Finke
    R P Ketterling
    R F McClure
    A Tefferi
    Leukemia, 2010, 24 : 1370 - 1372
  • [45] Two different del(5q) clones in a patient with myelodysplastic syndrome
    Braulke, Friederike
    Schanz, Julie
    Steffens, Rainer
    Liehr, Thomas
    Manvelyan, Marina
    Chudoba, Ilse
    Haase, Detlef
    LEUKEMIA & LYMPHOMA, 2011, 52 (09) : 1811 - 1814
  • [46] An Uncommon Case of a Child With del(5q) and Hypocellular Myelodysplastic Syndrome
    de Souza, Daiane Coriea
    Otero, Luize
    Tavares, Rita de Cassia
    Dobbin, Jane
    Abdelhay, Eliana
    Fernandez, Teresa de Souza
    PEDIATRIC BLOOD & CANCER, 2010, 55 (04) : 767 - 767
  • [47] Cause of Death in Patients With Lower-Risk Myelodysplastic Syndrome
    Dayyani, Farshid
    Conley, Anthony P.
    Strom, Sara S.
    Stevenson, William
    Cortes, Jorge E.
    Borthakur, Gautam
    Fader, Stefan
    O'Brien, Susan
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    CANCER, 2010, 116 (09) : 2174 - 2179
  • [48] Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion
    Jadersten, Martin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 348 - 351
  • [49] Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case
    Palacios-Campos, Adriana
    Gutierrez, Olga
    Fabian-Morales, Eunice
    Aviles, Alejandro
    Candelaria, Myrna
    REVISTA MEDICA DE CHILE, 2020, 148 (09) : 1357 - 1361
  • [50] Safety of Lenalidomide (LEN) 10mg in Non-Del(5q) Versus Del(5q) in the Treatment of Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (MDS): Pooled Analysis of Treatment-Emergent Adverse Events (TEAEs)
    Almeida, Antonio
    Santini, Valeria
    Croepper, Stefanie
    Jonasova, Anna
    Vey, Norbert
    Giagounidis, Aristoteles
    Hellstrom-Lindberg, Eva
    Mufti, Ghulam J.
    Sanz, Guillermo
    Skikne, Barry
    Hoenekopp, Albert
    Seguy, Francis
    Zhong, Jianhua
    Fenaux, Pierre
    BLOOD, 2015, 126 (23)
12345